Researchers have demonstrated that NEAT1 levels are significantly increased in a variety of tumors, including cholangiocarcinoma [26], colorectal cancer [35], and hepatocellular carcinoma [38]. Here, NEAT1 is linked to hepatocellular carcinoma.